
Eric Singhi/faculty.mdanderson.org
Sep 7, 2025, 07:11
Eric K. Singhi: Sequencing Absolutely Matters in Metastatic EGFR+ NSCLC
Eric K. Singhi, Thoracic Medical Oncologist at MD Anderson Cancer Center, shared a post on X:
“Sequencing absolutely matters in metastatic EGFR+ NSCLC.
Even with advances like combination therapy, 26–31% of these often younger, fit patients with EGFR+ disease never make it to 2L treatment.”
More from WCLC25 on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 7, 2025, 07:11
Sep 7, 2025, 06:55
Sep 7, 2025, 06:48
Sep 7, 2025, 06:44
Sep 7, 2025, 06:33
Sep 7, 2025, 06:07
Sep 7, 2025, 06:06
Sep 7, 2025, 05:55
Sep 7, 2025, 05:46
Sep 7, 2025, 05:24